Belt Buckling Vitrectomy Endolaser — Cost, Top Hospitals & Success Rates | MyMedicPlus

Belt buckling with vitrectomy and endolaser photocoagulation is a combined surgical approach for complex retinal detachments that cannot be reliably repaired by a single procedure alone. This technique integrates three established vitreoretinal interventions — scleral buckle placement, pars plana vitrectomy, and endolaser photocoagulation — into a single operative episode, providing maximal intraocular tamponade, vitreous removal, and permanent laser retinopexy simultaneously.

A scleral buckle (the 'belt') is an encircling silicone band or segmental explant sutured to the outer wall of the eye (sclera). It indents the scleral wall inward, physically pushing the detached retina back against the underlying retinal pigment epithelium (RPE) and relieving vitreoretinal traction at retinal breaks. Pars plana vitrectomy then removes the vitreous gel — which may be pulling on the retina due to posterior vitreous detachment, epiretinal membranes, or proliferative vitreoretinopathy (PVR) — and allows direct surgical access to the retinal surface. Endolaser photocoagulation is then applied around all retinal breaks, tears, and areas of vitreoretinal adhesion via a laser probe introduced through the vitrectomy ports, creating permanent chorioretinal adhesions (retinopexy) that seal the breaks against fluid re-entry. The vitreous cavity is filled at the end of surgery with either gas tamponade (SF6 or C3F8) or silicone oil, depending on the severity and chronicity of the detachment.

This combined approach is reserved for complex cases — typically where simpler procedures (pneumatic retinopexy or scleral buckle alone) have failed or are unlikely to succeed due to the complexity of retinal pathology. It is performed by specialist vitreoretinal surgeons at tertiary ophthalmology centres.

The primary indication for combined belt buckle, vitrectomy, and endolaser is complex rhegmatogenous retinal detachment complicated by proliferative vitreoretinopathy (PVR) — a fibrotic proliferative response where cells migrate onto the retinal surface and form contractile membranes that cause star-fold patterns and fixed retinal folds that cannot be flattened without vitrectomy and membrane peeling. PVR complicates approximately 8–10% of all retinal detachments and is the leading cause of surgical failure and re-detachment after primary retinal detachment repair.

Other indications include giant retinal tears (circumferential tears of 90 degrees or more), where the large flap of detached retina requires both scleral support and direct vitreous removal for controlled repositioning; tractional retinal detachments from proliferative diabetic retinopathy where fibrovascular membranes pull the retina off its pigment epithelial layer; combined tractional-rhegmatogenous detachments where both mechanical traction and retinal breaks coexist; re-detachment after prior failed primary repair; and detachments in eyes with previous vitreoretinal surgery, trauma, or silicone oil from prior procedures. High myopia is a risk factor that makes complex detachments more likely, and combined approaches are frequently needed in highly myopic eyes.

Candidates for combined belt buckle vitrectomy endolaser are patients with complex retinal detachments where the surgical complexity exceeds what can be managed with simpler approaches. Pre-operative assessment includes slit-lamp biomicroscopy, indirect ophthalmoscopy, B-scan ultrasonography (particularly when the view is obscured by haemorrhage or cataract), optical coherence tomography (OCT), and fluorescein angiography in relevant cases. The vitreoretinal surgeon evaluates the extent and duration of detachment, the presence and grade of PVR, the location and number of retinal breaks, the degree of vitreous haemorrhage, and prior surgical history.

Contraindications and considerations include very advanced PVR (grade D) with complete retinal rigidity where functional visual recovery is unlikely even with successful anatomical reattachment; eyes with no light perception for an extended period where the retina has degenerated; and patients medically unfit for surgery under anaesthesia. Relative contraindications include active ocular infection, uncontrolled intraocular pressure, and certain systemic conditions that increase surgical risk. Patients are counselled that even with technically successful surgery, visual recovery in complex detachments may be partial, particularly where the macula has been detached for more than one week.

Pars plana vitrectomy is performed using 23-, 25-, or 27-gauge transconjunctival sutureless vitrectomy systems, which minimise surgical trauma and enable faster wound healing compared with traditional 20-gauge systems. The vitreous is completely removed, followed by membrane peeling (epiretinal membrane, internal limiting membrane in appropriate cases, and PVR membranes) using endoforceps, scissors, and viscoelastic agents. Perfluorocarbon liquid (PFCL) — a heavy clear liquid denser than water — may be injected to flatten the retina and stabilise it during surgery before laser application. Endolaser photocoagulation creates 2–3 rows of burns around all breaks and areas of retinal pathology.

The choice of tamponade agent significantly influences the post-operative management. Gas tamponade (SF6 lasting 2–3 weeks; C3F8 lasting 6–8 weeks) requires the patient to maintain specific head positioning post-operatively to float the bubble against the repaired retinal area, and prohibits air travel until the gas has reabsorbed. Silicone oil tamponade is preferred for PVR grades C and D, inferior detachments, giant tears, and cases with compromised ability to position; it requires a second operation for silicone oil removal, typically 3–6 months later. The choice between gas and oil is individualised by the surgeon based on pathology severity and patient factors.

Selecting the most appropriate Belt Buckling Vitrectomy Endolaser approach requires a structured assessment of patient-specific factors. The treating specialist evaluates disease severity, prior treatment history, comorbidities, and patient preferences before recommending a specific protocol. Combination approaches are often more effective than monotherapy — integrating pharmacological, procedural, or rehabilitative elements to address multiple disease mechanisms simultaneously. Dose or intensity is titrated incrementally based on clinical response, tolerability, and objective outcome measures. In patients with refractory disease or inadequate response to first-line protocols, escalation to higher-intensity or specialist-delivered treatment options is indicated. Multidisciplinary team (MDT) review ensures that surgical, medical, and allied health perspectives are integrated into the final management plan, particularly for complex or high-risk cases where multiple treatment pathways are viable and the risk-benefit balance requires careful deliberation.

The combination of scleral buckling, vitrectomy, and endolaser delivers superior anatomical success rates for complex retinal detachments compared with any single procedure alone. Published series report primary anatomical success rates (single operation) of 75–90% for complex PVR-complicated detachments treated with combined surgery, with final anatomical success (after additional procedures) exceeding 90–95% in experienced hands. For giant retinal tears, combined approaches achieve reattachment in over 90% of cases.

The key benefit of adding a scleral buckle to vitrectomy in complex cases is providing permanent external support to the vitreous base region — reducing the risk of re-detachment from new breaks at the vitreous base not visible intraoperatively. Visual outcomes depend primarily on macular status: patients with macular-on detachments (macula attached at time of surgery) achieve better visual outcomes than those with macular-off detachments. When the macula has been detached, every day of delay in surgery reduces the chance of good visual recovery, reinforcing the urgency of prompt referral and surgical intervention.

Combined vitreoretinal surgery is associated with several specific complications. Elevated intraocular pressure occurs in approximately 10–20% of cases post-operatively, particularly when silicone oil is used, and requires topical or systemic pressure-lowering medications; severe cases may require silicone oil removal earlier than planned or surgical management of secondary glaucoma. Cataract formation is extremely common after vitrectomy (occurring in 70–80% of phakic patients within 2 years), frequently requiring cataract surgery at a separate sitting or combined cataract-vitrectomy.

Recurrent retinal detachment due to PVR re-growth occurs in approximately 10–15% of complex cases despite technically successful primary surgery and may require repeat vitrectomy with membrane peeling and silicone oil exchange. Choroidal haemorrhage during surgery is rare but sight-threatening. Endophthalmitis (intraocular infection) occurs in less than 0.05% of cases with modern sutureless systems but is devastating if it occurs. Scleral buckle-related complications include diplopia from extraocular muscle imbalance, anterior segment ischaemia in rare cases of excessive buckle tightening, and buckle exposure or extrusion requiring removal.

Immediately post-operatively, patients are reviewed in the recovery area with intraocular pressure check and slit-lamp examination. Strict face-down or head-down positioning is required when gas tamponade is used — typically 45–50 minutes per hour for the first 7–14 days — to direct the gas bubble against the repaired retinal area. This positioning requirement is one of the most challenging aspects of recovery and patients must be counselled and supported accordingly. Patients with silicone oil do not require strict positioning but are advised to sleep with the operated eye facing the treated retinal area.

Follow-up appointments are scheduled at 1 day, 1 week, 2 weeks, 1 month, and 3 months post-operatively for slit-lamp examination, indirect ophthalmoscopy, intraocular pressure measurement, and OCT of the macula. Visual acuity recovery is gradual — typically improving over 3–6 months as retinal function restores. If silicone oil was used, oil removal surgery is planned at 3–6 months. Driving restrictions apply until binocular vision is confirmed safe; return-to-work timelines range from 2–6 weeks depending on the nature of the work. Patients should promptly report any sudden vision loss, flashing lights, or new floaters suggesting re-detachment.

Complex vitreoretinal surgery requiring combined belt buckle, vitrectomy, and endolaser is among the more costly ophthalmic surgical procedures, reflecting the specialist equipment (high-speed vitrectomy machine, endolaser, wide-angle viewing system, PFCL, tamponade agents) and highly specialised surgical expertise required. In the United States, total costs including surgical and facility fees range from USD 10,000 to 25,000 per eye for complex vitreoretinal procedures. In the United Kingdom, private surgery costs range from GBP 4,000 to 10,000; NHS coverage applies for patients qualifying under standard referral pathways.

Indian ophthalmology centres, particularly at institutions such as Sankara Nethralaya, Aravind Eye Hospital, L.V. Prasad Eye Institute, and Narayana Nethralaya, offer world-class vitreoretinal surgical expertise at costs of USD 1,000–3,500 for complex combined procedures — representing 80–90% savings compared with US private costs. These centres perform extremely high surgical volumes, and their vitreoretinal surgeons have extensive experience with complex detachments. Thailand and Turkey also offer high-quality retinal surgery at significantly reduced international rates. Travel and accommodation costs must be factored into overall planning.

For less complex rhegmatogenous retinal detachments without PVR or giant tears, simpler procedures are preferred. Pneumatic retinopexy — an office-based procedure injecting a gas bubble and using cryotherapy or laser retinopexy — is appropriate for superior detachments with single, accessible breaks, with success rates of 70–80% for carefully selected cases. Scleral buckle alone (without vitrectomy) remains an excellent primary approach for young phakic patients with simple detachments, offering long-term support at the vitreous base without the risk of cataract induced by vitrectomy.

For tractional retinal detachments from proliferative diabetic retinopathy, early anti-VEGF injections (bevacizumab, ranibizumab) are sometimes used in the pre-operative period to reduce vascularity of fibrovascular membranes and reduce intraoperative haemorrhage risk, but they do not replace surgery. The decision between combined belt buckle plus vitrectomy versus vitrectomy alone for complex detachments is surgeon- and institution-dependent; some high-volume vitreoretinal centres achieve equivalent outcomes with vitrectomy alone for selected complex cases, reserving the buckle for specific vitreous base pathology.